Crispr Therapeutics recently received FDA and EMA approval for Casgevy. Read why CRSP stock is compelling investment in the ...

Jennifer Doudna, one of the inventors of the breakthrough gene-editing tool CRISPR, says the technology will help the world ...

Using state-of-the-art technology, researchers have identified several specific steps needed for CRISPR to become active and perform its gene editing function. These preclinical findings could lead to ...

For the past decade, scientists have relied almost exclusively on CRISPR-Cas systems for genome editing. Now, a smaller but ...

We expect CRISPR Therapeutics CRSP to surpass expectations when it reports third-quarter 2024 results. In the last reported ...

Ozempic and Wegovy, made by Novo Nordisk, are now listed as available across all doses on the FDA’s drug shortage list. But ...

CASGEVY™ approved for the treatment of patients 12 years of age and older with sickle cell disease (SCD) and transfusion-dependent beta ...

CRISPR Technology Market CRISPR Technology Market Dublin, Oct. 31, 2024 (GLOBE NEWSWIRE) -- The "CRISPR Technology Market" report has been added to ResearchAndMarkets.com's offering.The CRISPR ...

Evercore ISI analyst Liisa Bayko maintained a Hold rating on Crispr Therapeutics AG (CRSP – Research Report) today and set a price target ...

In 2014, CRISPR and CRISPR-associated (Cas ... significant investment challenges since the boom years of 2020 and 2021. However, signs of recovery are emerging, according to data shared by ...

Vertex leads the global development and commercialization of Casgevy under the terms of the 2021 agreement with support from CRISPR Therapeutics. Casgevy is the first marketed product in CRSP’s ...